Get Started

BIO.B

NYSE Bio-Rad Laboratories, Inc. Class B
Oct 24, 2026 · 9:58 AM ET EOD Market Closed

$364.15 ↑ +0.00 (+0.00%) Trading Up from the previous close of $364.15

YTD change
+0.00%
vs 20-day SMA
N/A
vs 200-day SMA
N/A

Price ranges

Previous day
$364.15 $364.21
open $364.21 close $364.15
-$0.06 (-0.02%)
Today
$0.00 $0.00
$364.15
Past week
$0.00 $364.15
from $364.15 now $364.15
+$0.00 (+0.00%)
Past month
$0.00 $364.15
from $364.15 now $364.15
+$0.00 (+0.00%)
This year
$244.54 $365.08
from $364.15 now $364.15
+$0.00 (+0.00%)

Price & Performance

+105.69 (+40.89%) / 6M

$246.78$289.13$331.49$373.84May 5Jun 23Oct 14

Signals & Sentiment

Momentum, market sentiment, and recent alerts

N/A
  • The stock is 0.3% away from all-time highs of $365.08
  • BIO.B is up 0% since the beginning of the year
  • BIO.B is up 0% over the past 12 months
  • BIO.B is up 0% over the past 1 month
  • 0% of all BIO.B investors are betting against BIO.B

BIO.B reads n/a: the 12-month move is +20.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes
EPS $2.62
Earnings momentum -17.8% Quarterly EPS growth
Quarterly change -17.8%

Valuation

P/E ratio N/A
Enterprise value $9.5B
Beta 1.24

Balance sheet & scale

Income$222.4K
Revenue$2.6B
Cash$1.6B
Debt$1.4M
Income / Debt 0.16×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNYSE
Sector Manufacturing
Sub Sector Computer and Electronic Product Manufacturing
Market cap $1.8B

Bio-Rad Laboratories, Inc. engages in the development, manufacturing, and marketing of a portfolio of instruments, systems, reagents, and consumables. It operates through the following segments: Life Science and Clinical Diagnostics. The Life Science segment includes development, manufacturing, and marketing of instruments, systems, reagents, and consumables used to separate, purify, characterize, and quantify biological materials. The Clinical Diagnostics segment focuses on designing, manufacturing, marketing, and support of diagnostic test systems, informatics solutions, test kits, and specialized quality controls for clinical laboratories in the global diagnostics market. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.

Competitor comparison

TickerCompany PriceChange
A Agilent Technologies, Inc. $173.07 -0.47%
WAT Waters Corporation $453.67 -0.42%
ILMN Illumina, Inc. $269.42 +0.01%
MTD Mettler-Toledo International Inc. $1,670.29 -0.85%
RVTY Revvity, Inc. $158.77 +0.90%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.